ACT Stress Management in Type 1 Diabetes
"Diabetes in Balance" - a Randomized Controlled Trial to Evaluate the Effects on Glucose Control, Self-care and Psychosocial Factors?
1 other identifier
interventional
81
1 country
1
Brief Summary
For many people living with type 1 diabetes it is a challenge to achieve good glucose control. Barely 20% reaches the goal level and many people experience self-care as complex, demanding and stressful. The purpose of this study is to evaluate the effect of a stress-management program on glucose control, self-care and psychosocial factors. The program is based on Acceptance and Commitment Therapy (ACT), a specific form of Cognitive behavior therapy (CBT). A total of 70 adult patients with type 1 diabetes from Ersta hospital will be recruited. Half of them will receive the intervention and the other half will continue with their regular diabetes care. A licensed psychologist specialised in CBT and a diabetes specialist nurse will be leading the intervention that is given in a group format. The program consists of seven 2-hour sessions given over 14 weeks. Glucose control, self care and stress will be measured at inclusion, after session four and seven, at six , 12 and 24 months and finally after 5 years
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2016
CompletedFirst Posted
Study publicly available on registry
September 26, 2016
CompletedStudy Start
First participant enrolled
October 15, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJuly 25, 2025
July 1, 2025
3.7 years
September 15, 2016
July 22, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
HbA1c
Measure of long term glucose control
12 months post inclusion
Secondary Outcomes (6)
Manchester Short Assessment of Quality of life
1-5 years post inclusion
Depression Anxiety stress scales
1-5 years post inclusion
The Hypoglycemia Fear Survey emotions, depression, anxiety, fear of hypoglycemia, general and diabetes related distress.
1-5 years post inclusion
The Problem Areas in Diabetes (Swe-PAID-20) Scale
1-5 years post inclusion
Acceptance and action diabetes questionnaire
1-5 years post inclusion
- +1 more secondary outcomes
Study Arms (2)
Diabetes in Balance
EXPERIMENTALThe intervention consists of the manual-based CBT-group intervention "Diabetes in Balance". It is given in a group format with six to ten participants and consists of 7 sessions. The sessions are given bi-weekly for two hours. Each session has a specific theme such as "Stress and acceptance" "The life-compass; what is important in my life". The participants also conduct assignments related to the themes between the sessions. A licensed psychologist specialised in CBT and a diabetes specialist nurse, both trained in "ACT-stress management" will be leading the intervention group.
Control
NO INTERVENTIONThe control group receives regular care including regular visits at the out-patient clinic, 3-4 times per year.
Interventions
ACT is a specific form of Cognitive behavior therapy (CBT) which will be given as a course consisting of seven sessions where each session is two hours long.
Eligibility Criteria
You may qualify if:
- Type 1 diabetes
- Duration of disease \>2 years -
- Hb1c\>60 mmol/mol
You may not qualify if:
- Insufficient knowledge to understand and express themselves in Swedish
- Untreated or severe ongoing psychiatric disease
- Cortisone treatment
- Untreated thyroid disease
- Insulin pump therapy started since \<3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ersta sjukhus
Stockholm, Stockholm County, 11691, Sweden
Related Publications (2)
Wijk I, Amsberg S, Johansson UB, Livheim F, Toft E, Anderbro T. Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial. BMJ Open. 2023 Dec 14;13(12):e072061. doi: 10.1136/bmjopen-2023-072061.
PMID: 38101850DERIVEDAmsberg S, Wijk I, Livheim F, Toft E, Johansson UB, Anderbro T. Acceptance and commitment therapy (ACT) for adult type 1 diabetes management: study protocol for a randomised controlled trial. BMJ Open. 2018 Nov 28;8(11):e022234. doi: 10.1136/bmjopen-2018-022234.
PMID: 30498037DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Therese Anderbro, AssProf
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 15, 2016
First Posted
September 26, 2016
Study Start
October 15, 2016
Primary Completion
June 30, 2020
Study Completion
December 31, 2025
Last Updated
July 25, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
Data will primarily be presented at the group level. Individual data will where appropriate be anonymised